ES2134221T3 - Sistemas mejorados del tipo de una vez al dia de administracion pulsatil de minociclina. - Google Patents

Sistemas mejorados del tipo de una vez al dia de administracion pulsatil de minociclina.

Info

Publication number
ES2134221T3
ES2134221T3 ES93101096T ES93101096T ES2134221T3 ES 2134221 T3 ES2134221 T3 ES 2134221T3 ES 93101096 T ES93101096 T ES 93101096T ES 93101096 T ES93101096 T ES 93101096T ES 2134221 T3 ES2134221 T3 ES 2134221T3
Authority
ES
Spain
Prior art keywords
distribution
minocycline
systems
distributing
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93101096T
Other languages
English (en)
Inventor
Nitin Vadilal Sheth
Joseph James Valorose Jr
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Keiran George Mooney
Jerry Bain Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2134221T3 publication Critical patent/ES2134221T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Magnetic Treatment Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Laser Surgery Devices (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

SE MUESTRAN SISTEMAS DE DISTRIBUCION FARMACEUTICA QUE CONTIENEN 7 DE ADICION ACIDA NO TOXICA CONSIGUIENTE Y QUE COMPRENDEN MEZCLAS DE UNA PROPORCION MENOR DE GRANULOS ESFERICOS RECUBIERTOS DE POLIMERO MEZCLADO DE DISTRIBUCION LENTA PARA DISTRIBUIR PARTE DE LA MINOCICLINA EN UN MEDIO CON UN PH MENOR DE 3,9 Y EL RESTO ENTRE 4,0 A 7,5 Y UNA PROPORCION MAYOR DE GRANULOS DE DISTRIBUCION RAPIDA NO RECUBIERTOS ADAPTADOS PARA DISTRIBUIR MINOCICLINA EN UN MEDIO CON UN PH INFERIOR A 3,9 Y CAPSULAS EN FORMA DE UNIDAD DE DOSIS ORAL QUE CONTIENEN LOS COMPONENTES ANTERIORES. ESTOS SISTEMAS Y FORMULACIONES OFRECEN NIVELES SANGUINEOS TERAPEUTICOS MEJORADOS DE MINOCICLINA PARA AL MENOS 24 HORAS CUANDO SE ADMINISTRAN A UN SUJETO UNA SOLA VEZ AL DIA, AL MARGEN DE SI EL PACIENTE ES ALIMENTADO O NO. SE OFRECEN TAMBIEN METODOS PARA LA PREPARACION DE LOS SISTEMAS Y FORMULACIONES.
ES93101096T 1992-03-02 1993-01-25 Sistemas mejorados del tipo de una vez al dia de administracion pulsatil de minociclina. Expired - Lifetime ES2134221T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/844,109 US5262173A (en) 1992-03-02 1992-03-02 Pulsatile once-a-day delivery systems for minocycline

Publications (1)

Publication Number Publication Date
ES2134221T3 true ES2134221T3 (es) 1999-10-01

Family

ID=25291839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93101096T Expired - Lifetime ES2134221T3 (es) 1992-03-02 1993-01-25 Sistemas mejorados del tipo de una vez al dia de administracion pulsatil de minociclina.

Country Status (24)

Country Link
US (2) US5262173A (es)
EP (1) EP0558913B1 (es)
JP (1) JPH069407A (es)
KR (1) KR100270491B1 (es)
CN (1) CN1039194C (es)
AT (1) ATE181504T1 (es)
AU (1) AU656841B2 (es)
CA (1) CA2090561C (es)
CZ (1) CZ283684B6 (es)
DE (1) DE69325402T2 (es)
DK (1) DK0558913T3 (es)
ES (1) ES2134221T3 (es)
FI (1) FI110163B (es)
GR (1) GR3031028T3 (es)
HU (1) HU219580B (es)
IL (1) IL104865A (es)
LV (1) LV12399B (es)
MX (1) MX9300998A (es)
NO (1) NO307170B1 (es)
NZ (1) NZ245951A (es)
PL (1) PL171609B1 (es)
SG (1) SG47785A1 (es)
TW (1) TW299235B (es)
ZA (1) ZA931444B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
AU7966694A (en) * 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
ZA974359B (en) * 1996-05-23 1998-05-12 Zeneca Ltd Microencapsulated compositions.
US5932437A (en) * 1998-04-13 1999-08-03 Genesis Laboratories, Inc. Control of lyme disease spirochete
ATE286725T1 (de) * 1998-10-01 2005-01-15 Novartis Pharma Gmbh Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
JP2000119181A (ja) * 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd エスクレチン及びその誘導体の放出制御経口製剤
NZ511442A (en) 1998-11-02 2003-02-28 Elan Corp Plc Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
EP1191924A4 (en) * 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT ADMINISTRATION OF (D-THREO) -METHYLPHENIDATE AND A SECOND STIMULANT OF THE CENTRAL NERVOUS SYSTEM
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
AU6521300A (en) * 1999-10-29 2001-05-14 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
KR20020059653A (ko) 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP1337244A4 (en) 2000-10-30 2006-01-11 Euro Celtique Sa HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
AU2002225763A1 (en) 2000-11-28 2002-06-11 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
EP2311440A1 (en) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
EP1405635A1 (en) * 2001-06-07 2004-04-07 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
RU2315603C2 (ru) 2002-12-20 2008-01-27 Ф.Хоффманн-Ля Рош Аг Композиция с высокой дозой ибандроната
CA2894736C (en) * 2003-04-07 2019-07-16 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
CA2602268A1 (en) * 2005-04-12 2006-10-19 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
US20080226734A1 (en) * 2007-03-16 2008-09-18 Elan Corporation Plc Combination of a narcotic and non-narcotic analgesic
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
KR20150084013A (ko) 2007-10-12 2015-07-21 다케다 파마슈티칼스 유에스에이, 인코포레이티드 음식 섭취와 관계없이 위장 장애를 치료하는 방법
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9314437B2 (en) 2011-04-22 2016-04-19 Napo Pharmaceuticals, Inc. Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA)
WO2012150246A1 (de) 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten freigabe von wirkstoffen
DE102011075354A1 (de) * 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
CN108414466A (zh) * 2018-03-09 2018-08-17 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片体外溶出测定方法
MA52980A (fr) * 2018-04-30 2021-04-28 Melinta Therapeutics Inc Procédés de traitement d'infections bactériennes à l'aide d'oritavancine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122039C (es) * 1960-10-20
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
EP0418565B1 (en) * 1989-09-21 1994-11-30 American Cyanamid Company Pulsatile once-a-day delivery system for minocycline
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation

Also Published As

Publication number Publication date
HK1009930A1 (en) 1999-06-11
AU656841B2 (en) 1995-02-16
CA2090561C (en) 2004-10-05
LV12399B (en) 2000-06-20
CZ30093A3 (en) 1994-02-16
NZ245951A (en) 1994-06-27
SG47785A1 (en) 1998-04-17
MX9300998A (es) 1993-09-01
HU9300570D0 (en) 1993-05-28
LV12399A (lv) 1999-12-20
PL171609B1 (pl) 1997-05-30
US5262173A (en) 1993-11-16
FI930906L (fi) 1993-09-03
IL104865A0 (en) 1993-06-10
PL297903A1 (en) 1993-11-15
DE69325402D1 (de) 1999-07-29
NO930743L (no) 1993-09-03
FI110163B (fi) 2002-12-13
DE69325402T2 (de) 2000-02-17
HUT64851A (en) 1994-03-28
KR100270491B1 (ko) 2000-11-01
AU3384293A (en) 1993-09-09
NO307170B1 (no) 2000-02-21
GR3031028T3 (en) 1999-12-31
EP0558913B1 (en) 1999-06-23
ATE181504T1 (de) 1999-07-15
CN1078889A (zh) 1993-12-01
IL104865A (en) 1997-02-18
CZ283684B6 (cs) 1998-06-17
CA2090561A1 (en) 1993-09-03
ZA931444B (en) 1993-10-14
EP0558913A1 (en) 1993-09-08
US5348748A (en) 1994-09-20
FI930906A0 (fi) 1993-03-01
CN1039194C (zh) 1998-07-22
NO930743D0 (no) 1993-03-01
TW299235B (es) 1997-03-01
JPH069407A (ja) 1994-01-18
KR930019209A (ko) 1993-10-18
HU219580B (hu) 2001-05-28
DK0558913T3 (da) 1999-12-13

Similar Documents

Publication Publication Date Title
ES2134221T3 (es) Sistemas mejorados del tipo de una vez al dia de administracion pulsatil de minociclina.
KR100249978B1 (ko) 방출제어형 갑상선 활성 조성물
ES2272827T3 (es) Parche terapeutico transdermico con capsaicina y analogos de capsaicina.
ES2279573T3 (es) Terapia para el estreñimiento.
YU49495B (sh) Formulacije oksikodona sa kontrolisanim otpuštanjem i njihova upotreba
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES2059710T3 (es) Granulados para composiciones orales de particulas multiples del tipo de liberacion controlada.
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
RU92004521A (ru) Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
CA2112679A1 (en) Dosage form for delivering drug in short-time period
AR022090A1 (es) PARTíCULAS PARA LA ADMINISTRACIoN DE UN AGENTE ACTIVO A LOS ALVÉOLOS DE UN PACIENTE HUMANO, UN MÉTODO PARA SU PREPARACIoN, Y EL USO DE LAS MISMAS PARA LA PREPARACIoN DE UN MEDICAMENTO PARA INHALACIoN
US2890984A (en) Pharmaceutical composition containing 2-(1, 2, 3, 4-tetrahydro-1-naphthyl)imidazo-line
ES2125324T3 (es) Film para suministro local de un farmaco para un tratamiento periodontal.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
US3621094A (en) Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts
WO1980000411A1 (en) Medication for afflictions of the skin and mucosa
DE69307807D1 (de) Naproxen-Tabletten mit gesteuerter Wirkstoffabgabe
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
EP0455503A1 (en) Composition for treating osteoporosis and hormonal imbalance
Jones et al. Dental management of idiopathic aplastic anemia: report of a case
ES2043567T1 (es) Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos.
EP0439858A1 (en) Veterinary phenytoin composition
SCHLESINGER Dental caries and the pediatrician
Elliott A Brief Clinical Report of the Use of Brevital, 1/2 Per Cent, for General Anesthesia in Oral Surgery

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558913

Country of ref document: ES